25th Apr 2025 Plain language summary of first-line treatment with amivantamab-lazertinib for high-risk EGFR-positive lung cancer from the MARIPOSA study
26th Jul 2022 The use of lumbar puncture and safety recommendations in Alzheimer’s disease: a plain language summary
